We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+2.66%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$2.52B
AUM Growth
+$1.08B
Cap. Flow
+$1.06B
Cap. Flow %
42.31%
Top 10 Hldgs %
3.65%
Holding
2,374
New
716
Increased
958
Reduced
387
Closed
293

Top Sells

Rank Stock Value
1
MDLZ icon
Mondelez International
MDLZ
+$7.04M
2
MBLY
Mobileye N.V.
MBLY
+$6.91M
3
GD icon
General Dynamics
GD
+$6.38M
4
NRG icon
NRG Energy
NRG
+$5.89M
5
ECL icon
Ecolab
ECL
+$5.62M

Sector Composition

Rank Sector Weight
1 Healthcare 15.93%
2 Industrials 13.24%
3 Technology 13.05%
4 Consumer Discretionary 12.97%
5 Financials 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSNI
176
DELISTED
HSN, Inc.
HSNI
$2.9M 0.12%
42,575
+11,000
+35% +$774K
SSNC icon
177
SS&C Technologies
SSNC
$18.6B
$2.89M 0.12%
+92,902
New +$2.76M
WBD icon
178
Warner Bros
WBD
$65.4B
$2.88M 0.11%
93,668
+85,433
+1,037% +$2.68M
ANIP icon
179
ANI Pharmaceuticals
ANIP
$1.82B
$2.86M 0.11%
45,727
-27
-0.1% -$1.64K
VFC icon
180
VF Corp
VFC
$5.87B
$2.86M 0.11%
40,293
+32,923
+447% +$2.28M
TLYS icon
181
Tilly's
TLYS
$121M
$2.85M 0.11%
182,274
+83,780
+85% +$1.12M
DBI icon
182
Designer Brands
DBI
$331M
$2.85M 0.11%
+77,178
New +$2.83M
MDCO
183
DELISTED
Medicines Co
MDCO
$2.83M 0.11%
+100,978
New +$2.84M
USNA icon
184
Usana Health Sciences
USNA
$422M
$2.8M 0.11%
50,464
+5,764
+13% +$295K
IDT icon
185
IDT Corp
IDT
$1.65B
$2.8M 0.11%
223,653
+189,549
+556% +$2.75M
LMNX
186
DELISTED
Luminex Corp
LMNX
$2.79M 0.11%
174,580
+98,214
+129% +$1.65M
MCK icon
187
McKesson
MCK
$96.8B
$2.79M 0.11%
12,334
-3,076
-20% -$682K
PENN icon
188
PENN Entertainment
PENN
$2.67B
$2.78M 0.11%
177,745
+25,300
+17% +$398K
CAKE icon
189
Cheesecake Factory
CAKE
$5.21B
$2.77M 0.11%
56,173
+34,101
+154% +$1.72M
INCY icon
190
Incyte
INCY
$24B
$2.74M 0.11%
29,892
+25,615
+599% +$2.12M
AGU
191
DELISTED
Agrium
AGU
$2.73M 0.11%
26,219
+21,727
+484% +$2.32M
IONS icon
192
Ionis Pharmaceuticals
IONS
$9.06B
$2.73M 0.11%
42,901
+38,150
+803% +$2.59M
MRK icon
193
Merck
MRK
$316B
$2.72M 0.11%
49,607
-680
-1% -$38.5K
SNDK
194
DELISTED
SANDISK CORP
SNDK
$2.71M 0.11%
42,549
+30,543
+254% +$2.48M
OUTR
195
DELISTED
OUTERWALL INC
OUTR
$2.7M 0.11%
40,857
+28,660
+235% +$1.92M
ASH icon
196
Ashland
ASH
$3.29B
$2.7M 0.11%
43,286
+29,103
+205% +$1.76M
KKR icon
197
KKR & Co
KKR
$95.7B
$2.69M 0.11%
+118,122
New +$2.79M
CDW icon
198
CDW
CDW
$18.9B
$2.69M 0.11%
72,249
+47,049
+187% +$1.71M
JLL icon
199
Jones Lang LaSalle
JLL
$16.8B
$2.69M 0.11%
15,763
+1,366
+9% +$216K
VAL
200
DELISTED
Valspar
VAL
$2.69M 0.11%
31,959
+25,874
+425% +$2.23M

Similar funds

GSA Capital Partners's Q1 2015 Portfolio in Review

As of Q1 2015, GSA Capital Partners held 2,374 positions worth $2.52B, up 75% from $1.43B the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.

GSA Capital Partners deployed $1.06B of net new capital in Q1 2015, opening 716 new positions and adding to 958 existing holdings. Its largest new stake was Du Pont De Nemours E I: 152,589 shares worth $10.4M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was General Dynamics, an estimated $6.38M trimmed.

  • GSA Capital Partners's largest Q1 2015 buy was Du Pont De Nemours E I: 152,589 shares worth $10.4M.
  • GSA Capital Partners added most to Altria Group in Q1 2015, an estimated $7.74M increase.
  • GSA Capital Partners's biggest Q1 2015 reduction was General Dynamics, cutting an estimated $6.38M.
  • GSA Capital Partners fully exited Mondelez International in Q1 2015, selling an estimated $7.04M.
  • GSA Capital Partners's ten largest holdings make up 3.7% of its $2.52B portfolio in Q1 2015.
  • GSA Capital Partners opened 716 new positions and closed 293 in Q1 2015.
  • GSA Capital Partners's portfolio value rose 75% quarter-over-quarter to $2.52B.

Based on GSA Capital Partners's 13F filing for Q1 2015, filed 14 May 2015.